Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease

Author： Reinders Claudia   Jonkers Daisy   Jansson Emmelie Å.   Stockbrügger Reinhold   Stobberingh Ellen   Hellström Per   Lundberg Jon  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.42, Iss.10, 2007-01, pp. : 1151-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease

By Aomatsu Tomoki  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2372-2377

Springer Publishing Company

Access to resources Recommend Favorite

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

By Kolho Kaija-Leena   Raivio Taneli   Lindahl Harry   Savilahti Erkki  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 720-725

Informa Healthcare

Access to resources Recommend Favorite

Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

By  

Digestive Diseases, Vol. 31, Iss. 3-4, 2013-11 ,pp. : 336-344

Karger

Access to resources Recommend Favorite

Rectal NO and fecal calprotectin in IBD

By Lundberg Jon  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 1, 2009-01 ,pp. : 128-128

Informa Healthcare

Access to resources Recommend Favorite

Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases

By Tursi Antonio   Elisei Walter   Giorgetti GianMarco   Picchio Marcello   Brandimarte Giovanni  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 11, 2013-11 ,pp. : 1359-1360

Informa Healthcare

Access to resources Recommend Favorite